John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 25,000 shares at $44.18 ($1.1M) on 2015-06-04, disclosed to the SEC on 2015-06-08.
Open-market sale of $1.1M ALDR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |